×

img Acces sibility Controls

Research Projects Banner

Research Projects

Development & assessment of P-32-labelled arabinogalactan & Cu-64-labelled arabinogalactan for asialoglycoprotein receptor directed therapy of hepatocellular carcinoma

Funding Organization
Funding Organization

Quick Information
Area of Research
Medical Sciences
Focus Area
Medical Research
Start Year
2020
End Year
2021
Sanction Amount
₹ 24.12 L
Status
Completed
Output
No. of Research Paper
00
Technologies (If Any)
00
No. of PhD Produced
N/A
Startup (If Any)
00
No. of Patents
Filed :00
Grant :00
arrowtop